| Ex. AGY-FED-HEALTH-OTHER-064 | VA announcement of Mar. 10, 2020: 'No Visitor' stance and suspension of new admissions at all VA nursing homes (community living centers) and spinal cord injury and disorder centersVA announces safeguards to protect nursing home and spinal cord injury patients | Department of Veterans Affairs (Secretary Robert Wilkie) | United States (federal); Department of Veterans Affairs, Veterans Health AdministrationFederal | Mar. 10, 2020 | 2020 Q22020 Q3 | Context (guidance or announcement)Gathering capHealth care orders | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-027 | COVID-19 Public Health Emergency Response and 42 CFR Part 2 GuidanceCOVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance | SAMHSA | United States (federal); Substance Abuse and Mental Health Services AdministrationFederal | Mar. 19, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Context (guidance or announcement)Health care ordersOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-041 | Guidance for Industry: Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) (Mar. 19, 2020; updated Mar. 27 and Apr. 15, 2020, and later)Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) | Food and Drug Administration, CDER | United States (federal); Food and Drug Administration, Center for Drug Evaluation and ResearchFederal | Mar. 19, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Context (guidance or announcement)Supply chainOther | Primary source read | |
| Ex. AGY-DEFENSE-GUARD-103 | COVID-19: Service reductions, closures, cancellations, updates (running notice, published Apr. 16, 2020; first posted Mar. 20, 2020)COVID-19: Service reductions, closures, cancellations, updates | 96th Test Wing, Eglin AFB (published on eglin.af.mil) | Eglin Air Force Base, Florida (96th Test Wing)Federal | Apr. 16, 2020 | 2020 Q22020 Q3 | Context (guidance or announcement)Business closureCapacity limitFace-covering requirementHealth care ordersCurfew and hours | Primary source read | |
| Ex. AGY-DEFENSE-GUARD-106 | Release, Partnering with the U.S. Defense Industrial Base to Combat COVID-19 (Mar. 22, 2020)Partnering with the U.S. Defense Industrial Base to Combat COVID-19 | Department of Defense (statement attributed to Lt. Col. Mike Andrews) | Department of Defense (Defense Industrial Base)Federal | Mar. 22, 2020 | 2020 Q2 | Context (guidance or announcement)Business closureSupply chain | Confirmed from a secondary source | |
| Ex. AGY-FED-HEALTH-OTHER-043 | Guidance for Industry and FDA Staff: Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (March 2020)Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public… | Food and Drug Administration, CDRH | United States (federal); Food and Drug Administration, Center for Devices and Radiological HealthFederal | Mar. 22, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Context (guidance or announcement)Health care ordersSupply chainOther | Primary source read | |
| Ex. AGY-USCG-PORTS-056 | CSMS #42124872Information for Filing Personal Protective Equipment and Medical Devices During COVID-19 | U.S. Customs and Border Protection, Office of Trade (relaying FDA) | U.S. Customs and Border Protection with the Food and Drug Administration; all ports of entryFederal | Mar. 23, 2020 | 2020 Q2 | Context (guidance or announcement)Supply chainOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-042 | Guidance for Industry: Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) (Mar. 24, 2020; updated Mar. 27 and Apr. 15, 2020, and later)Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency… | Food and Drug Administration, CDER | United States (federal); Food and Drug Administration, Center for Drug Evaluation and ResearchFederal | Mar. 24, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Context (guidance or announcement)Supply chainOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-044 | Guidance: Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Mar. 25, 2020; revised Apr. 2020, May 2020, Sept. 2021; superseded Sept. 5, 2023)Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency | Food and Drug Administration, CDRH | United States (federal); Food and Drug Administration, Center for Devices and Radiological HealthFederal | Mar. 25, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Context (guidance or announcement)Face-covering requirementSupply chainOther | Confirmed from a secondary source | |
| Ex. AGY-FED-HEALTH-OTHER-045 | Guidance for Industry: Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency (Mar. 26, 2020)Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency | Food and Drug Administration, CFSAN | United States (federal); Food and Drug Administration, Center for Food Safety and Applied NutritionFederal | Mar. 26, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Context (guidance or announcement)Supply chainOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-066 | VA announcement of Mar. 27, 2020 releasing the VHA COVID-19 Response Plan: elective and non-emergent procedures postponed; outpatient care shifted to telehealthVA Releases COVID-19 Response Plan | Department of Veterans Affairs | United States (federal); Department of Veterans Affairs, Veterans Health AdministrationFederal | Mar. 27, 2020 | 2020 Q2 | Context (guidance or announcement)Telework mandateHealth care orders | Primary source read | |
| Ex. AGY-DEFENSE-GUARD-160 | Release, Fort Worth District Evaluates Sites for Use as Alternate Care Facilities (Mar. 29, 2020)Fort Worth District evaluates sites for use as alternate care facilities | USACE Fort Worth District | U.S. Army Corps of Engineers, Fort Worth District (Texas alternate care facilities)Federal | Mar. 29, 2020 | 2020 Q2 | Context (guidance or announcement)Health care ordersEvents and venues | Confirmed from a secondary source | |
| Ex. AGY-USCG-PORTS-013 | Seventh District MSIB 01-20Medical Capability Requirements for Foreign Passenger Vessels Impacted by the Novel Coronavirus | Rear Admiral E. C. Jones, Commander, Seventh Coast Guard District, Miami, Florida | United States Coast Guard, Seventh District (Florida, Georgia, South Carolina, Puerto Rico, U.S. Virgin Islands and adjacent waters)Federal | Mar. 29, 2020 | 2020 Q22020 Q32020 Q4 | Context (guidance or announcement)Travel and quarantineHealth care ordersQuarantine and isolationOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-028 | OTP Guidance for Patients Quarantined at Home with the Coronavirus (doorstep delivery protocol) (updated Mar. 30, 2020)OTP Guidance for Patients Quarantined at Home with the Coronavirus | SAMHSA, Division of Pharmacologic Therapies, Center for Substance Abuse Treatment | United States (federal); Substance Abuse and Mental Health Services AdministrationFederal | Mar. 30, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Context (guidance or announcement)Health care ordersQuarantine and isolationOther | Primary source read | |
| Ex. AGY-AVIATION-SURFACE-045 | DOT COVID-19 Drug & Alcohol Testing Statement of Enforcement Discretion for Substance Abuse Professionals and Service Agents (Apr. 4, 2020)DOT COVID-19 Drug & Alcohol Testing Statement of Enforcement Discretion for Substance Abuse Professionals and Service Agents | U.S. Department of Transportation, Office of Drug and Alcohol Policy and Compliance (ODAPC) | United States (U.S. Department of Transportation, Office of Drug and Alcohol Policy and Compliance; all DOT-regulated employers in aviation, trucking, rail, transit, pipelines and maritime)Federal | Apr. 4, 2020 | 2020 Q2 | Context (guidance or announcement)Health care ordersWorkplace rulesOther | Primary source read | |
| Ex. AGY-USCG-PORTS-061 | CSMS #42320854Processing International Donations for COVID-19 Response | U.S. Customs and Border Protection, Office of Trade | U.S. Customs and Border Protection with FEMA and the Department of State; all ports of entryFederal | Apr. 9, 2020 | 2020 Q22020 Q3 | Context (guidance or announcement)Supply chainOther | Primary source read | |
| Ex. AGY-DEFENSE-GUARD-107 | Release, First DoD Defense Production Act Title 3 COVID-19 Project (Apr. 11, 2020)First DOD Defense Production Act Title 3 COVID-19 Project | Department of Defense | Department of Defense (Defense Production Act Title III program)Federal | Apr. 11, 2020 | 2020 Q2 | Context (guidance or announcement)Supply chain | Confirmed from a secondary source | |
| Ex. AGY-DEFENSE-GUARD-108 | Release, DOD Details $133 Million Defense Production Act Title 3 COVID-19 Project (Apr. 21, 2020)DOD Details $133 Million Defense Production Act Title 3 COVID-19 Project | Department of Defense | Department of Defense (DPA Title III)Federal | Apr. 21, 2020 | 2020 Q2 | Context (guidance or announcement)Supply chain | Confirmed from a secondary source | |
| Ex. AGY-DEFENSE-GUARD-127 | I Corps & JBLM COVID-19 Response Factsheet, Update 13 (as of Apr. 21, 2020)I Corps & JBLM COVID-19 Response Factsheet (Update 13) | I Corps and Joint Base Lewis-McChord | Joint Base Lewis-McChord, WashingtonFederal | Apr. 21, 2020 | 2020 Q2 | Context (guidance or announcement)Business closureGathering capFace-covering requirementTravel and quarantineSchools and child careHealth care orders | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-025 | FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergencyFAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency | SAMHSA, Center for Substance Abuse Treatment, Division of Pharmacologic Therapies | United States (federal); Department of Health and Human Services, Substance Abuse and Mental Health Services AdministrationFederal | Apr. 21, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Context (guidance or announcement)Health care ordersOther | Primary source read | |
| Ex. AGY-DEFENSE-GUARD-109 | Release, DOD Details $75 Million Defense Production Act Title 3 Puritan Contract (Apr. 29, 2020)DOD Details $75 Million Defense Production Act Title 3 Puritan Contract | Department of Defense | Department of Defense (DPA Title III)Federal | Apr. 29, 2020 | 2020 Q2 | Context (guidance or announcement)Supply chain | Confirmed from a secondary source | |
| Ex. AGY-FED-LANDS-SCIENCE-COURTS-002 | Secretary's letters of May 5, 2020 to meat and poultry processors and to governors ('Secretary Perdue Issues Letters on Meat Packing Expectations', USDA release of May 6, 2020)Secretary Perdue Issues Letters on Meat Packing Expectations | Secretary of Agriculture Sonny Perdue | United States Department of AgricultureFederal | May 5, 2020 | 2020 Q2 | Context (guidance or announcement)Workplace rulesSupply chain | Confirmed from a secondary source | |
| Ex. AGY-DEFENSE-GUARD-110 | Release, DOD Awards $126 Million Contract to 3M, Increasing Production of N95 Masks (May 6, 2020)DOD Awards $126 Million Contract to 3M, Increasing Production of N95 Masks | Department of Defense | Department of Defense (DPA Title III)Federal | May 6, 2020 | 2020 Q2 | Context (guidance or announcement)Supply chain | Confirmed from a secondary source | |
| Ex. AGY-DEFENSE-GUARD-111 | Release, DOD Announces $77.3 Million in Defense Production Act Title III COVID-19 Actions (July 24, 2020)DOD Announces $77.3 Million in Defense Production Act Title III COVID-19 Actions | Department of Defense | Department of Defense (DPA Title III)Federal | July 24, 2020 | 2020 Q3 | Context (guidance or announcement)Supply chain | Confirmed from a secondary source | |
| Ex. AGY-FED-HEALTH-OTHER-021 | DEA-DC-043 (EO-DEA213), guidance: Administering certain controlled substances in the parking lot of a health care provider's DEA-registered location during the COVID-19 public health emergencyAdministering Certain CS in the parking lot of a healthcare provider's DEA-registered location during the COVID-19 public health emergency | Drug Enforcement Administration, Diversion Control Division (guidance document EO-DEA213) | United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal | July 28, 2020 | 2020 Q32020 Q42021 Q12021 Q22021 Q3 | Context (guidance or announcement)Health care ordersOther | Primary source read | |